141 related articles for article (PubMed ID: 8891089)
21. Hypochondriacal concerns in depressed outpatients.
Demopulos C; Fava M; McLean NE; Alpert JE; Nierenberg AA; Rosenbaum JF
Psychosom Med; 1996; 58(4):314-20. PubMed ID: 8827793
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
[TBL] [Abstract][Full Text] [Related]
23. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Nierenberg AA; Pava JA; Clancy K; Rosenbaum JF; Fava M
Biol Psychiatry; 1996 Oct; 40(8):691-6. PubMed ID: 8894060
[TBL] [Abstract][Full Text] [Related]
24. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
Besançon G; Cousin R; Guitton B; Lavergne F
Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
[TBL] [Abstract][Full Text] [Related]
25. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
[TBL] [Abstract][Full Text] [Related]
26. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
Zhang WJ; Yang XB; Zhong BL
J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
[TBL] [Abstract][Full Text] [Related]
28. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
29. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
Small GW; Birkett M; Meyers BS; Koran LM; Bystritsky A; Nemeroff CB
J Am Geriatr Soc; 1996 Oct; 44(10):1220-5. PubMed ID: 8856002
[TBL] [Abstract][Full Text] [Related]
30. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
[TBL] [Abstract][Full Text] [Related]
31. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
32. [Effects of antidepressant therapy in patients with suspected "angina pectoris" and negative coronary angiogram complicating comorbid depression].
Zheng AL; Qi WH; Hu DY; Cai NS; Ge JB; Fan WH; Ni YF; Lu GP; Zhang FR; Wei M; He B; Wu SY; Sun BG; Wu ZG; Jin HG; Huang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1097-100. PubMed ID: 17274900
[TBL] [Abstract][Full Text] [Related]
33. Escitalopram in the treatment of anxiety symptoms associated with depression.
Bandelow B; Andersen HF; Dolberg OT
Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
[TBL] [Abstract][Full Text] [Related]
34. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
35. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
Farabaugh A; Sonawalla S; Johnson DP; Witte J; Papakostas GI; Goodness T; Clain A; Baer L; Mischoulon D; Fava M; Harley R
Ann Clin Psychiatry; 2010 Aug; 22(3):166-71. PubMed ID: 20680189
[TBL] [Abstract][Full Text] [Related]
36. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
39. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
De Wilde J; Spiers R; Mertens C; Bartholomé F; Schotte G; Leyman S
Acta Psychiatr Scand; 1993 Feb; 87(2):141-5. PubMed ID: 8447241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]